DRKS00031548
Recruiting
Phase 4
observational comparative study: Intravitreal treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) with a bispecific antibody Vabysmo® (faricimab) vs. a classical anti-VEGF inhibitor Eylea® (aflibercept) in a treat-and-extend-regimen (FATE). - FATE
Augenklinik der Medizinischen Hochschule Hannover0 sites136 target enrollmentMarch 24, 2023
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- H35.30
- Sponsor
- Augenklinik der Medizinischen Hochschule Hannover
- Enrollment
- 136
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Consenting patients with macular edema, with underlying cause: neovascular age\-related macular degeneration, diabetes mellitus\-related maculopathy.
- •Minimum age 18 years, gender male/female/diverse.
Exclusion Criteria
- •Macular edema caused or influenced by an underlying cause other than neovascular age\-related macular degeneration or diabetes mellitus\-related maculopathy.
- •lack of capacity to consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Comparative study of the effect of intravitreal injection of bevacizumab versus simultaneous intravitreal injection of bevacizumab and triamcinolone acetonideRetinal vascular occlusions.Retinal vascular occlusionsIRCT20130812014333N185Kermanshah University of Medical Sciences58
Completed
Not Applicable
Evaluation of treatment options of central serous chorioretinopathyCentral Serous Chorioretinoathy.Central Serous ChorioretinopathyIRCT2017041533448N1Vice chancellor for research, Zahedan University of Medical Sciences30
Completed
Not Applicable
Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with Central Retinal Vein Occlusion : A Randomized Clinical Trialthe efficacy of triamcinolone and bevacizumabwas measured in patients with Central Retinal Vein OcclusionBevacizumab,Intravitreal Injections,Retinal Vein Occlusion,TriamcinoloneTCTR20170612005rmia university of medical sciences90
Completed
Phase 4
Interindividual Comparison Trial – Two intraocular lenses with extended depth of focusCataractH26.9Cataract, unspecifiedDRKS00010594niversitätsklinikum Knappschaftskrankenhaus Bochum GmbH Augenklinik43
Unknown
Not Applicable
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on macular edema secondary to branch retinal vein occlusioMacular edema secondary to branch retinal vein occlusionJPRN-UMIN000001546Shiga University of Medical Science, department of Ophthalmology60